Preview

Rational Pharmacotherapy in Cardiology

Advanced search

CHOICE OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND CHRONIC LIVER DISEASES

https://doi.org/10.20996/1819-6446-2008-4-4-65-68

Full Text:

Abstract

A number of comorbid patients is increasing significantly. Chronic diffusive liver diseases meet at 40 % of patients with hypertension. Lisinopril advantages in patients with hypertension and diffusive liver diseases are shown in the article on example of concrete study.

About the Authors

M. N. Mamedov
State Research Center of Preventive Medicine of Rosmedtechnology, Petroverigsky per. 10, Moscow, 101990 Russia
Russian Federation


O. M. Drapkina
Clinic of Propaedeutics of Internal Medicine, Moscow Medical Academy named after M.I. Setchenov
Russian Federation


References

1. Athyros V.G., Liberopoulos E.N., Mikhailidis D.P. et al. Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort. Angiology 2007;58(6):689-97.

2. Mamedov M.N., Suslonova N.V., Lisenkova I.Yu. et al. Metabolic syndrome prevalence in Russia: preliminary results of a cross-sectional population study. Diab Vasc Dis Res 2007; 4 Suppl 1:S46-47

3. Zafrani E.S. Non-alcoholic fatty liver disease: an emerging pathological spectrum. Virchows Arch 2004;444 (1):3-12

4. Драпкина О.М., Тутнов Д.А. Особенности лечения артериальной гипертензии у больных с заболеваниями печени. Российские медицинские вести 2008;(3):43-8.

5. Абдурахманов Д.Т. Алкогольный гепатит: клиническая характеристика, течение и прогноз. Фарматека 2008;(2):25-33.

6. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-97.

7. Кутишенко Н.П., Марцевич С.Ю. Лизиноприл в кардиологической практике: данные доказательной медицины. Рационал Фармакотер Кардиол 2007;(5):79-83.

8. Кательницкая Л.И., Хаишева Л.А., Глова С.Е. Суммарный сердечно-сосудистый риск у больных с гипертонической болезнью: возможности ингибиторов ангиотензинпревращающего фермента. Рационал Фармакотер Кардиол 2007;(5):9-14.


For citation:


Mamedov M.N., Drapkina O.M. CHOICE OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND CHRONIC LIVER DISEASES. Rational Pharmacotherapy in Cardiology. 2008;4(4):65-68. (In Russ.) https://doi.org/10.20996/1819-6446-2008-4-4-65-68

Views: 325


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)